Amrep [AXR] vs Alset [AEI] Detailed Stock Comparison

Amrep
NYSE
Loading...

Alset
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Amrep wins in 12 metrics, Alset wins in 6 metrics, with 0 ties. Amrep appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Amrep | Alset | Better |
---|---|---|---|
P/E Ratio (TTM) | 9.59 | -6.47 | Alset |
Price-to-Book Ratio | 0.93 | 0.45 | Alset |
Debt-to-Equity Ratio | 0.02 | 3.12 | Amrep |
PEG Ratio | 0.67 | -0.01 | Alset |
EV/EBITDA | 5.68 | -29.70 | Alset |
Profit Margin (TTM) | 27.54% | -77.86% | Amrep |
Operating Margin (TTM) | 34.43% | -245.60% | Amrep |
EBITDA Margin (TTM) | 34.43% | N/A | N/A |
Return on Equity | 10.39% | -16.63% | Amrep |
Return on Assets (TTM) | 6.19% | -2.91% | Amrep |
Free Cash Flow (TTM) | $9.66M | $5.05M | Amrep |
1-Year Return | -20.07% | 83.11% | Alset |
Price-to-Sales Ratio (TTM) | 2.61 | 6.77 | Amrep |
Enterprise Value | $76.49M | $87.38M | Alset |
EV/Revenue Ratio | 1.58 | 5.44 | Amrep |
Gross Profit Margin (TTM) | 44.78% | 23.29% | Amrep |
Revenue per Share (TTM) | $9 | $2 | Amrep |
Earnings per Share (Diluted) | $2.48 | $-1.05 | Amrep |
Beta (Stock Volatility) | 1.27 | 1.41 | Amrep |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Amrep vs Alset Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Amrep | -1.43% | -3.38% | 9.02% | 3.49% | 26.14% | -24.40% |
Alset | -2.52% | 3.83% | 23.18% | 148.62% | 256.58% | 96.38% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Amrep | -20.07% | 104.98% | 264.70% | 405.39% | 114.16% | -12.24% |
Alset | 83.11% | -39.24% | -51.17% | -51.17% | -51.17% | -51.17% |
Performance & Financial Health Analysis: Amrep vs Alset
Metric | AXR | AEI |
---|---|---|
Market Information | ||
Market Cap | $130.78M | $109.04M |
Market Cap Category | Micro cap | Micro cap |
10 Day Avg. Volume | 8,360 | 187,400 |
90 Day Avg. Volume | 12,723 | 1,154,787 |
Last Close | $23.45 | $2.71 |
52 Week Range | $17.60 - $39.67 | $0.70 - $4.55 |
% from 52W High | -40.89% | -40.44% |
All-Time High | $149.99 (Jan 15, 2007) | $589.80 (Feb 15, 2021) |
% from All-Time High | -84.37% | -99.54% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.07% | -0.03% |
Quarterly Earnings Growth | 0.16% | -0.02% |
Financial Health | ||
Profit Margin (TTM) | 0.28% | -0.78% |
Operating Margin (TTM) | 0.34% | -2.46% |
Return on Equity (TTM) | 0.10% | -0.17% |
Debt to Equity (MRQ) | 0.02 | 3.12 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $25.56 | $6.22 |
Cash per Share (MRQ) | $9.28 | $0.83 |
Operating Cash Flow (TTM) | $9.08M | $4.68M |
Levered Free Cash Flow (TTM) | $4.99M | $-2,257,780 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Amrep vs Alset
Metric | AXR | AEI |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 9.59 | -6.47 |
Forward P/E | 12.46 | N/A |
PEG Ratio | 0.67 | -0.01 |
Price to Sales (TTM) | 2.61 | 6.77 |
Price to Book (MRQ) | 0.93 | 0.45 |
Market Capitalization | ||
Market Capitalization | $130.78M | $109.04M |
Enterprise Value | $76.49M | $87.38M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.58 | 5.44 |
Enterprise to EBITDA | 5.68 | -29.70 |
Risk & Other Metrics | ||
Beta | 1.27 | 1.41 |
Book Value per Share (MRQ) | $25.56 | $6.22 |
Financial Statements Comparison: Amrep vs Alset
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | AXR | AEI |
---|---|---|
Revenue/Sales | $17.85M | $1.07M |
Cost of Goods Sold | $9.86M | $777,529 |
Gross Profit | $7.99M | $290,774 |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $6.15M | $-3.30M |
EBITDA | $6.22M | $-3.34M |
Pre-Tax Income | $6.60M | $-9.46M |
Income Tax | $1.91M | $42,948 |
Net Income (Profit) | $4.69M | $-9.50M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | AXR | AEI |
---|---|---|
Cash & Equivalents | $39.47M | $25.19M |
Total Current Assets | $107.46M | $54.06M |
Total Current Liabilities | $3.79M | $4.82M |
Long-Term Debt | $26,000 | $836,103 |
Total Shareholders Equity | $129.96M | $84.81M |
Retained Earnings | $96.02M | $-260.19M |
Property, Plant & Equipment | $2.63M | $609,976 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | AXR | AEI |
---|---|---|
Operating Cash Flow | $4.79M | $-10.16M |
Capital Expenditures | $0 | $-61,244 |
Free Cash Flow | $2.53M | $-3.82M |
Debt Repayment | $-2,000 | $-280,074 |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | AXR | AEI |
---|---|---|
Shares Short | 24,803 | 77,607 |
Short Ratio | 2.20 | 0.06 |
Short % of Float | 0.01% | 0.00% |
Average Daily Volume (10 Day) | 8,360 | 187,400 |
Average Daily Volume (90 Day) | 12,723 | 1,154,787 |
Shares Outstanding | 5.29M | 9.24M |
Float Shares | 2.87M | 4.02M |
% Held by Insiders | 0.45% | 0.90% |
% Held by Institutions | 0.45% | 0.01% |
Dividend Analysis & Yield Comparison: Amrep vs Alset
Metric | AXR | AEI |
---|---|---|
Last 12-Month Dividend | $0.00 | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | $0.00 | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | $0.00 | N/A |
Ex-Dividend Date | N/A | N/A |